Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-01-12
1996-09-24
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530399, 530850, 514885, 514 12, A61K 3802
Patent
active
055590977
ABSTRACT:
Methods and compositions are provided for maintaining pregnancy and preventing rejection of transplanted tissue. A polypeptide characterized as capable of isolation from conceptus tissue and capable of inhibiting mitogen induced lymphocyte blastogenesis is employed which is introduced into the uterus or systemically.
REFERENCES:
patent: 4554256 (1983-07-01), Sasser
patent: 4705748 (1983-11-01), Sasser
Sasser, et al., J. Reprod Fert. Suppl 37, 1989, pp. 109-113.
Balton et al., The Lancet Mar. 1987, pp. 593-595.
Newton et al., Am J. Reprod Immunol 19, 1989, pp. 99-107.
"Identification of Placental Protein as a Immunosuppressive Factor in Human Reproduction", by A. E. Bolton et al., in The Lancet, Mar. 14:593-595 (1987).
"Suppression of Interleukin-2-Mediated T-Lymphocyte Blastogenesis by Ovine Uterine Luminal Protein", by E. C. Segerson, Jr. et al., in Biology of Reproduction, 38:256-263 (1988).
"Human Pregnancy Serum Inhibits Proliferation of T8-Depleted Cells and their Interleukin-2 Synthesis in Mixed Lymphocyte Cultures", by C. G. Domingo et al., in Journal of Reproductive Immunology, 8:97-110 (1985).
"Inhibition of Lymphocyte Proliferation by Ovine Trophoblast Protein-1 and a High Molecular Weight Glycoprotein Produced by the Peri-Implantation Sheep Conceptus", by G. R. Newton et al., in American Journal of Reproductive Immunology, 19:99-107 (1989).
"Suppression of Lymphocyte Activation by a High-Molecular-Weight Glycoprotein Released from Preimplantation Ovine and Porcine Conceptuses", by M. K. Murray et al., in American Journal of Reproductive Immunology and Microbiology, 14:38-44 (1987).
"The Influence of Protein Hormones and Conceptus Extracts on Sheep Lymphocyte Transformation Induced in Vitro", by L. D. Staples et al., in :125-131 (1983).
"The Influence of Embryonic Tissue Homogenate Infused into the Uterus, on the Life-Span of the Corpus Luteum in the Sheep", by L. E. A. Rowson and R. M. Moor, in J. Reprod. Fert., 13:511-516 (1967).
"Human Pregnancy Serum Inhibits Interleukin-2 Production", by N. S. Nicholas et al., in Clinical Experimental Immunology, 58:587-595 (1984).
"Interrelationships Between Uterus and Conceptus to Maintain Corpus Luteum Function in Early Pregnancy: Sheep, Cattle, Pigs and Horses", by W. W. Thatcher, et al., in J. Admin, Sci., 62:25-46 (1986).
"Isolation and Partial Characterization of an Antigen Associated with Pregnancy in the Ewe" by L. D. Staples, in Biology of Reproduction, 22:675-685 (1980).
"Suppression of Phytohemagglutinin-Stimulated Lymphocyte Blastogenesis by Ovine Uterine Milk Protein" by E. Segerson, et al., Biology of Reproduction, 30:1175-118 (1984).
"Characterization of Immunosuppressive Substances in the Basic Protein Fraction of Uterine Secretions from Pregnant Ewes" by P. J. Hansen, et al., Biology of Reproduction, 36:393-403 (1987).
"Effect of Embryo Removal and Intrauterine Infusion of Embryonic Homogenates on the Lifespan of the Bovine Corpus Luteum" by D. L. Northey and L. R. French, Journal of Animal Science, 50:298-302 (1980).
"Trophoblastin, as antiluteolytic protein present in early pregnancy in sheep" by J. Martal, et al., J. Reprod. Fert., 56:63-73 (1979).
"Proteins released by cultured day 15-16 conceptuses prolong luteal maintenance when introduced into the uterine lumen of cyclic ewes" by J. D. Godkin, et al., in J. Reprod. Fert., 71:57-64 (1984).
"Immunosuppressive Effect of Ovine Uterine Secretory Protein upon Lymphocytes in vitro" by E. C. Segerson, in Biology of Reproduction, 25:77-84 (1981).
"Characterization of Pregnancy-Specific Protein B in Cattle" by L. D. Staples, in Biology of Reproduction, 37:109-113 (1989).
"Ovine Trophoblast Protein 1, and Early Secreted Blastocyst Protein, Binds Specifically to Uterine Endometrium and Affects Protein Synthesis by Godkin", in The Endocrine Society, 114:120-130 (1984).
Segerson et al., CA vol. 101, #2089325, 1984.
Sergerson et al. CA vol. 101 #37126a, 1984.
Roberts et al. CA, vol. 110, #210621u, 1989.
Hansen et al., CA vol. 107, #21779d, 1987.
Niwano et al., Am J Reprod Immunol, 1989, 20, p. 21-26 (Abstract only).
Watson, CA, vol. 112, 196471c, 1990.
Draper Garnette D.
Idaho Research Foundation Inc.
Spector L.
LandOfFree
Use of a pregnancy specific protein as an immunosuppressive does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a pregnancy specific protein as an immunosuppressive, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a pregnancy specific protein as an immunosuppressive will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928485